A single mutation in the HBB gene causes sickle cell disease by changing the shape and function of red blood cells. This article explores the biology behind the disease, its connection to malaria, and how CRISPR gene editing therapies such as Casgevy and India’s Birsa‑101 aim to correct the mutation at its source.